Research Figures
Data from the Scientific Report 2022
- 525 Projects
- 406 Clinical Trials
- 816 Publications
- 5563 Total Impact Factor
News
Efficacy of a drug demonstrated in preclinical models to halt rhabdomyosarcoma growth
The research team led by the Institut de Recerca Joan de Déu (IRSJD) and the Hospital del Mar Research Institute has, for the first time, demonstrated the efficacy of a drug in animal models developed from samples of patients from the Sant Joan de Déu Hospital.
The Fundació Sant Joan de Déu (FSJD) will lead the European guideline for the transition of young cancer patients from paediatric to adult hospitals within the YARN project
The Fundació Sant Joan de Déu (FSJD) is taking part in the European Youth Cancer Network (YARN) project, an initiative that expands on the work previously developed in EU-CAYAS-NET and OACCUs to strengthen the European network of young people affected by cancer. The project promotes peer support, the use of digital tools, and access to reliable information, especially for those facing relapses, metastatic cancer, or treatment-related side effects.
Interviews
Susana Ochoa Güerre
Psychologist, head of the Research Group on Etiopathogenesis and Treatment of Severe Mental Disorders (MERITT) at the Institut de Recerca Sant Joan de Déu (IRSJD) and head of research at the Parc Sanitari Sant Joan de Déu (PSSJD).
Agenda
TECSAM | Communication and mental health: transforming stigma into respectful narrative
Maria Lomascolo: social psychologist and head of mental health and stigma care projects at Obertament.